Centiva Capital’s Manhattan Associates MANH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,622
Closed -$1.15M 1857
2025
Q1
$1.15M Buy
+6,622
New +$1.38M 0.03% 412
2024
Q2
Sell
-3,063
Closed -$766K 2327
2024
Q1
$766K Sell
3,063
-7,736
-72% -$1.84M 0.02% 789
2023
Q4
$2.33M Buy
10,799
+9,637
+829% +$2.04M 0.06% 310
2023
Q3
$230K Sell
1,162
-5,893
-84% -$1.15M 0.01% 1317
2023
Q2
$1.41M Buy
7,055
+4,818
+215% +$837K 0.03% 482
2023
Q1
$346K Buy
+2,237
New +$308K 0.01% 993
2022
Q4
Sell
-2,765
Closed -$368K 1516
2022
Q3
$368K Buy
+2,765
New +$374K 0.01% 980
2022
Q1
Sell
-1,355
Closed -$211K 1727
2021
Q4
$211K Buy
+1,355
New +$220K ﹤0.01% 990

Other funds holding MANH

Centiva Capital's MANH Position: Q2 2025 in Review

Centiva Capital sold out of Manhattan Associates (MANH) in Q2 2025, closing a stake of 6,622 shares — an estimated $1.15M sold.

Centiva Capital first reported a position in MANH in Q4 2021 and held it in 8 quarters. The position peaked at $2.33M in Q4 2023. 591 funds tracked by Wall St. Rank hold MANH as of Q2 2025.

  • Centiva Capital reported no remaining Manhattan Associates position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 6,622 Manhattan Associates shares in Q2 2025, an estimated $1.15M.
  • Centiva Capital first reported a position in Manhattan Associates in Q4 2021 and held it in 8 quarters.
  • Centiva Capital's Manhattan Associates position peaked at $2.33M in Q4 2023.
  • 591 funds tracked by Wall St. Rank held Manhattan Associates as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.